Technical Comparison
Virax Biolabs Group Limited - Ordinary Shares vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between VRAX and NVDA.
Primary Asset
VRA
Virax Biolabs Group Limited - Ordinary Shares
Market Rank #1005166Live Price$2.93
Market Capitalization$2.3M
24h Change+1.38%
Circulating Supply797K VRAX
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$190.01
Market Capitalization$4.6T
24h Change-3.55%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | VRAX Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1005166 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $2.93 | $190.01 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $2.3M | $4.6T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is Virax Biolabs Group Limited - Ordinary Shares bigger than NVIDIA Corporation - Common Stock?
Virax Biolabs Group Limited - Ordinary Shares has a market cap of $2.3M, while NVIDIA Corporation - Common Stock sits at $4.6T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between Virax Biolabs Group Limited - Ordinary Shares and NVIDIA Corporation - Common Stock?
Currently, 1 VRAX is worth 0.02 NVDA.